CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.
“There are a lot of studies in the nontransplant-eligible population presented, and I think that that space has not had a lot of movement,” Mazzoni, hematologist with the Cleveland Clinic, said. “I’m glad to see it’s starting to have more movement and bringing a lot of these new therapies up front.”
